CCKBR and morphine dependence: It has been reported that several CCK2 receptor antagonists such as L-365,260, PD134,308 and LY-288,513, but not CCK1 receptor antagonist such as L-364,718, attenuate the development of morphine dependence and naloxone-precipitated withdrawal symptoms [26], [27].